As the ferroptosis pathway is a possible target for cancer treatment (Dierge et al. 2021), ELOVL5 could be a marker for determining whether ferroptosis-mediated treatment is applicable (Lee et al. 2020). This evidence concerns the gene ELOVL5 and cancer.